Feature Image

Medical Marijuana, Inc. CEO Featured Speaker at California Cannabis Business Expo, Change.org Petition Seeks to Engage Trump Administration

SAN DIEGO, March 6, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, is pleased to announce that the Company’s Chief Executive Officer Dr. Stuart Titus is a featured speaker at the California Cannabis Business Expo taking place in San DiegoMarch 5-8.

Dr. Titus will speak on March 8 on the history and applicability of cannabis as a medicine. Medical Marijuana, Inc. subsidiary HempMeds® will showcase at booth #311 some of their Real Scientific Hemp Oil™ (RSHO™) cannabidiol (CBD) hemp-based products, highlight a new customer affiliate program, and put a spotlight on a young advocate working to make a sweeping change in federal marijuana policy.

“We are pleased to be taking part in the California Cannabis Business Expo,” said Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc. “Our participation in this tradeshow gives us a chance to showcase our products and take an active role in the community we are focused on supporting. Additionally, we are especially happy to be joined by a special guest — Sadie Higuera, as she spearheads a Change.org campaign to garner acknowledgment of the medicinal benefits of cannabis by the Trump administration.”

HempMeds® will be placing a spotlight on Sadie Higuera, a local San Diego girl attempting to meet President Trump and change U.S. policy toward cannabis as a Schedule 1 drug. Sadie suffers from a rare and terminal genetic disorder and her family hopes that through a Change.org petition, their appeal will be met with a response from the White House.

On Display, HempMeds flagship RSHO products, in original paste form, MCT Liquid Oil and then RSHO Capsules and was the first cannabis-based product to be legalized into a Latin American country (BrazilApril 2014) for the treatment of refractory epilepsy – the type of epilepsy that is resistant to pharmaceutical intervention. Additionally, RSHO-X™ a fully THC free version was legalized into Mexico as of Feb., 1 2016 as the first cannabis based product to be so accepted, again for refractory epilepsy indications. Today, HempMeds remains the only legal cannabis supplier to Mexico. This product would also qualify as the first cannabis-based product to qualify for World Anti-Doping Standards, as athletes can take this CBD-rich product without concern for failing a drug test.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

About HempMeds®

HempMeds® is a corporate portfolio company of Medical Marijuana, Inc.(OTC PINK: MJNA) and the Company’s exclusive master distributor and contracted marketing company, handling sales and distribution.

FORWARD-LOOKING DISCLAIMER AND DISCLOSURES

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties. The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.

CONTACT:

Public Relations Contact:

Andrew Hard

Chief Executive Officer

CMW Media

P. 888-829- 0070

andrew.hard@cmwmedia.com

www.cmwmedia.com